Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement

NCT01240902 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

1453

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Aortic Stenosis

Interventions

DEVICE: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
DEVICE: Surgical Aortic Valve Replacement (SAVR)

Sponsor

Medtronic Cardiovascular